Diazoxide ameliorates severity of experimental osteoarthritis by activating autophagy via modulation of the osteoarthritis-related biomarkers.

Meng, ZhuLong

Diazoxide ameliorates severity of experimental osteoarthritis by activating autophagy via modulation of the osteoarthritis-related biomarkers. [electronic resource] - Journal of cellular biochemistry 11 2018 - 8922-8936 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1097-4644

10.1002/jcb.27145 doi


ADAMTS5 Protein--metabolism
Animals
Autophagy--drug effects
Biomarkers--blood
Blotting, Western
Cell Survival--drug effects
Chondrosarcoma--drug therapy
Collagen Type II--metabolism
Diazoxide--therapeutic use
Humans
Male
Matrix Metalloproteinase 13--metabolism
Microscopy, Electron, Transmission
Osteoarthritis--drug therapy
RNA, Messenger--metabolism
Rats